Early interferon-β-1b of BENEFIT for MS?

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1600, 2007-01, pp. : 1-1

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Interferon-β-1b of benefit in early multiple sclerosis

By  

Inpharma, Vol. 1, Iss. 1512, 2005-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite

Interferon-β-1a and interferon-β-1b have comparable efficacy in MS

By  

Inpharma, Vol. 1, Iss. 1540, 2006-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

IFN- -1b has greater bioactivity than IFN- -1a in MS?

By  

Inpharma, Vol. 1, Iss. 1245, 2000-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

Interferon-β1b for the treatment of multiple sclerosis

By Lam Sum   Wang Shan   Gottesman Malcolm  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 8, 2008-08 ,pp. : 1111-1117

Informa Healthcare

Access to resources Recommend Favorite

Interferon-β1b in the treatment of multiple sclerosis

By Río Jordi   Montalban Xavier  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 16, 2005-12 ,pp. : 2877-2886

Informa Healthcare

Access to resources Recommend Favorite